MedPath

The Optimise Study - randomised trial of the use of a decision aid to improve informed choice regarding the benefits of low-dose aspirin to prevent cardiovascular disease and colorectal cancer

Not Applicable
Conditions
cardiovascular disease
colorectal cancer
gastrointestinal bleeding
Registration Number
ACTRN12618001219279
Lead Sponsor
niversity of Sydney
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
1780
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath